Endometrial ablation for prevention of recurrent endometrial pathology in postmenopausal breast cancer patients receiving tamoxifen
Objective. To comparatively assess treatment and prevention methods for endometrial changes in postmenopausal patients taking tamoxifen. Subjects and methods. One hundred twenty three tamoxifen-treated women with breast cancer who had the endometrium more than 5 mm by USG. All the examinees were pos...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IP Berlin A.V.
2015-02-01
|
| Series: | Гинекология |
| Subjects: | |
| Online Access: | https://gynecology.orscience.ru/2079-5831/article/viewFile/28413/pdf |
| Summary: | Objective. To comparatively assess treatment and prevention methods for endometrial changes in postmenopausal patients taking tamoxifen. Subjects and methods. One hundred twenty three tamoxifen-treated women with breast cancer who had the endometrium more than 5 mm by USG. All the examinees were postmenopausal. The study evaluated the effectiveness of the coagulation hysteroresectoscopic endometrial ablation. Results. The results of treatment were assessed at 12 months. Patients of the first group recurrence of endometrial pathology detected in 1,4% of cases, while in the second group 60%. Conclusion. Thus, by analyzing the results of hysteroresectoscopic endometrial ablation and only diagnostic hysteroscopy in patients with endometrial pathology receiving adjuvant therapy for breast cancer, it was demonstrated that the efficiency of ablation is much higher than hysteroscopy and curettage (98,6 and 40% respectively). |
|---|---|
| ISSN: | 2079-5696 2079-5831 |